MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5543/tkda.2015.35984

Медицинская библиотека · Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir · 2015

An epidemiological study to evaluate the use of vitamin K antagonists and new oral anticoagulants among non-valvular atrial fibrillation patients in Turkey- AFTER-2 study design.

Ertaş Faruk, Kaya Hasan, Yıldız Abdulkadir, Davutoğlu Vedat, Kiriş Abdulkadir, Dinç Lale, Kafes Habibe, Avcı Anıl, Calapkorur Bekir, Ertaş Gökhan, Gül Mehmet, Kahraman Ay Nuray, Bulur Serkan, Durukan Mine, Eren Murat, İlhan İbrahim, Küçük Murathan, Özpelit Ebru, Şimşek Hakkı, Uçar F Mehmet, Yıldız Ahmet, Şahin D Yıldıray, Ayhan Erkan, Çağlayan C Emre, Güngör Hasan, Özyurtlu Ferhat, Şen Nihat, Vatan Bülent, Vatansever Fahriye, Kobat Mehmet Ali, Temiz Ahmet, Taylan Gökay, Dönmez İbrahim, Erkuş M Emre, Söylemez Selami, Zengin Halit, Gündüz Mahmut, Tuncez Abdullah, Karavelioğlu Yusuf, Gökdeniz Tayyar, Koza Yavuzer, Aktop Ziyaeddin, Katlandur Hüseyin, Karaca Özer Pelin, Yüksel Murat, Acet Halit, Çil Habib, Alan Sait, Toprak Nizamettin

Клиническое исследованиеСтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

Atrial fibrillation (AF) is one of the most common causes of preventable ischemic stroke and is related to increased cardiovascular morbidity and mortality. There is a lack of data in Turkey on the use of new oral anticoagulants (NOACs), and time in therapeutic INR range (TTR) in vitamin K antagonist users and AF management modality. In this multi-center trial, we aimed to analyze, follow and evaluate the epidemiological data in non-valvular AF patients.

STUDY

DESIGN

Four thousand one hundred consecutive adult patients from 42 centers with at least one AF attack identified on electrocardiography will be included in the study. Patients with rheumatic mitral valve stenosis and prosthetic valve disease will be excluded from the study. At the end of one year, the patients will be evaluated in terms of major cardiac end points (death, transient ischemic attack, stroke, systemic thromboembolism, major bleeding and hospitalization).

RESULTS

First results are expected in June 2015. Data about major cardiovascular end-points will be available in January 2016.

CONCLUSION

The rates and kind of oral anticoagulant use, TTR in vitamin K antagonist users and main management modality applied in non-valvular AF patients will be determined by AFTER-2 study. In addition, the rate of major adverse events (MACEs) and the independent predictors of these MACEs will be detected (AFTER-2 Study ClinicalTrials.gov number, NCT02354456.).

Для цитирования: Ertaş Faruk, Kaya Hasan, Yıldız Abdulkadir, Davutoğlu Vedat, Kiriş Abdulkadir, Dinç Lale, Kafes Habibe, Avcı Anıl, Calapkorur Bekir, Ertaş Gökhan, Gül Mehmet, Kahraman Ay Nuray, Bulur Serkan, Durukan Mine, Eren Murat, İlhan İbrahim, Küçük Murathan, Özpelit Ebru, Şimşek Hakkı, Uçar F Mehmet, Yıldız Ahmet, Şahin D Yıldıray, Ayhan Erkan, Çağlayan C Emre, Güngör Hasan, Özyurtlu Ferhat, Şen Nihat, Vatan Bülent, Vatansever Fahriye, Kobat Mehmet Ali, Temiz Ahmet, Taylan Gökay, Dönmez İbrahim, Erkuş M Emre, Söylemez Selami, Zengin Halit, Gündüz Mahmut, Tuncez Abdullah, Karavelioğlu Yusuf, Gökdeniz Tayyar, Koza Yavuzer, Aktop Ziyaeddin, Katlandur Hüseyin, Karaca Özer Pelin, Yüksel Murat, Acet Halit, Çil Habib, Alan Sait, Toprak Nizamettin. An epidemiological study to evaluate the use of vitamin K antagonists and new oral anticoagulants among non-valvular atrial fibrillation patients in Turkey- AFTER-2 study design.. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2015. DOI: 10.5543/tkda.2015.35984.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.